Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,367 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07045779Recruiting
Tongue and mouth muscle patterns in children with open bite
This study looks at children with an anterior open bite to understand their tongue and mouth muscle patterns. It may help find better ways to treat this condition.
GhentAges 6–12 - NCT06649500Recruiting
Comparing two balance therapy methods for older adults
This trial tests whether a high-tech treadmill (Walker View) or group therapy works better for improving balance and preventing falls in older adults. It also uses artificial intelligence to predict fall risk early.
Rome, RomeAges 65 years+ - NCT07658989Recruiting
Blood thinners in pregnancy with mechanical heart valves
This study looks at the best way to manage blood thinners for pregnant people who have mechanical heart valves. It aims to find the safest approach for both the mother and the baby.
Toronto, OntarioAges 18–45 - NCT07675213Recruiting
Uterine muscle movements and pregnancy after frozen embryo transfer
This trial explores how natural uterine contractions affect pregnancy success in women using hormone therapy for frozen embryo transfer. It may help doctors understand if uterine activity influences implantation.
Ho Chi Minh CityAges 18–42 - NCT07488442Recruiting
Cognitive behavioral therapy for chronic constipation
This trial tests if cognitive behavioral therapy can help people with a specific type of chronic constipation called dyssynergic defecation. If you have had constipation for over a year and meet some specific tests, this therapy might improve your symptoms.
Ankara, YenimahalleAges 18–55 - NCT07500714Recruiting
Digital therapy for depression using AI
This study uses a smartphone app and artificial intelligence to deliver a special type of talk therapy for people with moderate to severe depression. It aims to provide personalized care without needing to change your current treatment.
Taichung, TaichungAges 18–75 - NCT07484750Recruiting
Mindfulness group therapy for OCD
This trial tests a type of group therapy that combines mindfulness with exposure techniques to help people with obsessive-compulsive disorder (OCD) manage their symptoms. If you have OCD and are between 16 and 55 years old, you may be able to join.
Shanghai, Shanghai MunicipalityAges 16–55 - NCT07408804Recruiting
Lenvatinib alone vs. with chemoembolization for liver cancer
This trial compares the combination of two treatments—chemoembolization (TACE) and lenvatinib—against lenvatinib alone for people with liver cancer that cannot be removed by surgery. It aims to see if the combination works better.
DhakaAges 18–75 - NCT07303855Recruiting
Better fluid management after major abdominal surgery
This study compares two ways of giving fluids to people after major abdominal surgery in the ICU. It will see if using a measure of how much blood the heart pumps (cardiac index) is better than the usual method based on vein pressure.
Jakarta Pusat, DKI JakartaAges 18–65 - NCT07281352RecruitingPhase 1/Phase 2
Psilocybin therapy for depression
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
Los Angeles, CaliforniaAges 21–60 - NCT07243327Recruiting
Shockwave therapy vs standard rehab for hip pain
This trial compares two treatments—shockwave therapy and conventional physical therapy—for long-lasting pain on the outside of the hip, often called trochanteric pain syndrome. It aims to find which option works better for people whose hip pain has persisted for months.
IstanbulAges 18–65 - NCT07225010Recruiting
Video Parenting Program for Young Children with Behavior Problems
This study tests a special parenting program (Parent-Child Interaction Therapy) done through video calls. It aims to help children aged 2–6 with behavior problems and to strengthen family relationships.
Charleston, South CarolinaAges 2–7 - NCT07173153Enrolling by invitationPhase 1/Phase 2
Gene therapy study for SLC6A1 genetic disorder
This trial tests a gene therapy for people with a specific mutation (S295L) in the SLC6A1 gene, which causes a neurodevelopmental disorder. The therapy aims to correct the genetic issue, and participants will be monitored closely for safety and effectiveness.
Columbus, OhioAges Any age - NCT07119710Recruiting
Telehealth support for rural dementia caregivers
This study tests if telehealth support can improve quality of life for family caregivers of people with dementia living in rural Texas. You would receive guidance and resources through video or phone calls from home.
Lubbock, TexasAges 18–110 - NCT07027930Recruiting
EMDR group therapy for traffic accident trauma
This study tests a type of therapy called EMDR (which uses eye movements to help process trauma) in a group setting for people who are still struggling with stress symptoms from a past road traffic accident. It aims to see if this approach is helpful and practical.
Lahore, Punjab ProvinceAges 18–45 - NCT07747974Recruiting
Therapy for spastic cerebral palsy in children
This study compares two types of hand and arm therapy to help children with spastic cerebral palsy use their affected side better. Children will either practice with the affected hand through special exercises or use mirror therapy, which uses a mirror to create the illusion of movement.
IslamabadAges 5–9 - NCT07748533RecruitingPhase 1
CAR T-cell therapy for hard-to-treat autoimmune hemolytic anemia
This trial tests a new treatment using your own immune cells (CAR T-cells) to stop them from attacking your red blood cells. It is for people with autoimmune hemolytic anemia or Evans syndrome who have not improved after at least 3 previous treatments.
TianjinAges 18–75 - NCT06796504Recruiting
Nerve stimulation for relapsing-remitting multiple sclerosis
This trial tests a device that stimulates a nerve in the neck, which may help repair the protective coating around nerves in the brain and spinal cord. It is for people with relapsing-remitting MS who are stable on their current medication and have some vision problems due to MS.
Irvine, CaliforniaAges 22–60 - NCT06660355RecruitingPhase 2
Comparing two medicines for chronic graft-versus-host disease
This trial compares two treatments, ruxolitinib and prednisone, as the first therapy for chronic graft-versus-host disease (cGVHD), a condition where donor cells attack your body after a stem cell transplant. The goal is to see which medicine works better and has fewer side effects.
Miami, FloridaAges 18 years+ - NCT05673148RecruitingPhase 3
Ablation treatment plus usual therapy for limited metastatic bowel cancer
This study tests whether adding “total ablation” (carefully destroying all visible small tumors using surgery, heat/cold treatment, and/or targeted radiation) to standard chemotherapy improves outcomes for people with limited spread of colorectal cancer. It may help by aiming to eliminate all known metastatic spots while you continue usual cancer treatment.
Kingman, ArizonaAges 18 years+ - NCT06800209RecruitingPhase 2
Pain Reprocessing Therapy for ongoing knee pain after replacement
This study tests if Pain Reprocessing Therapy can help reduce knee pain that continues 3 months after a knee replacement. It uses a telehealth approach so you can participate from home.
Aurora, ColoradoAges 18 years+ - NCT06296017Recruiting
Comparing nonsurgical treatments for trigger finger
This study compares nonsurgical treatments (like exercises, splints, or injections) for trigger finger. It aims to find which conservative approach works best for mild cases without surgery.
AnkaraAges 18–65 - NCT07156227RecruitingPhase 1
Testing camonsertib with radiation for returning head and neck cancer
This study tests whether adding the drug camonsertib to radiation therapy can help people whose head and neck cancer has come back in a spot that was already treated with radiation. Camonsertib is an experimental drug that may help radiation work better.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06931340RecruitingPhase 3
Adding chemo to hormone therapy for advanced prostate cancer
This trial is for men with metastatic prostate cancer that has already spread beyond the pelvis. It tests whether adding a chemotherapy drug (docetaxel) to the usual hormone therapy plus apalutamide can help control the cancer better than hormone therapy alone.
Tucson, ArizonaAges 18 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,367 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.